InterRayBio

InterRayBio is a biotechnology startup and contract research organization (CRO) specializing in structure-based drug design, assay development, and biophysical characterization. Founded in 2015, the company leverages over 40 years of combined expertise in biochemistry, molecular biology, protein production, X-ray crystallography, and Surface Plasmon Resonance (SPR) to support drug discovery campaigns. InterRayBio collaborates with academic institutions and other biotech startups to identify target hotspots, perform in silico virtual library screenings, and develop small molecule inhibitors and protein-protein interaction (PPI) stabilizers. Its research and consulting services span therapeutic areas such as oncology, infectious diseases (including malaria and COVID-19), and cystic fibrosis.